Presentation6 signs
- 01Profound fatigue lasting 6+ months
- 02Post-exertional malaise
- 03Unrefreshing sleep
- 04Cognitive impairment (brain fog)
- 05Orthostatic intolerance
- 06Immune dysfunction
A constellation, not a disease.
HHHC · clinical index
Nº 03.6Hormone-related conditions
ME/CFS carries documented hormonal abnormalities — blunted HPA axis, low DHEA-S, subclinical thyroid dysfunction. We look carefully for the treatable endocrine drivers inside a genuinely complex condition.
Presentation6 signs
A constellation, not a disease.
HHHC · clinical index
The pathway
Stage · 01
Consult
60-minute in-person assessment with your doctor.
Stage · 02
Test
Full hormone panel, thyroid, metabolic markers.
Stage · 03
Protocol
Bioidentical prescription tuned to your results.
Stage · 04
Follow up
Monitored adjustments as your body responds.
The Hormonal Dimension
Myalgic encephalomyelitis/chronic fatigue syndrome is a systemic neuroimmune condition characterised by profound fatigue, post-exertional malaise, and cognitive dysfunction. While the full pathophysiology remains under investigation, multiple studies have documented significant endocrine abnormalities in ME/CFS patients.
These include a blunted cortisol awakening response, reduced DHEA-S levels, impaired pregnenolone synthesis, and subclinical hypothyroidism with poor T4-to-T3 conversion. Neuroinflammation — microglial activation in the brain — has been demonstrated on PET imaging and provides a rationale for low-dose naltrexone therapy.
We do not claim to cure ME/CFS, but by identifying and correcting the hormonal and nutritional deficiencies that are common in this condition, many patients experience meaningful improvements in energy, cognition, and quality of life.
Diagnostic Criteria
Based on IOM 2015 and NICE 2021 diagnostic frameworks.
Evidence-Based Approach
Targeting the treatable hormonal and neuroimmune components of ME/CFS.
4-point salivary cortisol mapping to document cortisol rhythm abnormalities. Targeted support with DHEA, pregnenolone, and adaptogenic strategies where deficiency is documented.
1.5-4.5mg nightly for neuroinflammation modulation. Emerging case series data showing improvement in fatigue, cognitive function, and quality of life in ME/CFS.
Comprehensive panel including reverse T3 and TPO antibodies. T3 combination therapy for documented poor T4-to-T3 conversion. Many CFS patients have subclinical thyroid dysfunction.
Targeted repletion of iron (ferritin >70), vitamin D, B12, magnesium, and CoQ10. Addressing the nutritional deficiencies that impair energy metabolism.
Learn more about our comprehensive approach to hormone-driven conditions.
Next step
Book a consultation to explore whether hormonal factors are contributing to your exhaustion.